Tongyan Liu

2.9k total citations · 1 hit paper
55 papers, 2.0k citations indexed

About

Tongyan Liu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Tongyan Liu has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Tongyan Liu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Tongyan Liu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Tongyan Liu collaborates with scholars based in China, Japan and United Kingdom. Tongyan Liu's co-authors include Rong Yin, Chencheng Han, Lin Xu, Siwei Wang, Zhifei Ma, Panqi Fang, Guo‐Qing Zhu, Yu‐Ming Kang, Hai‐Jian Sun and Juejin Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Tongyan Liu

48 papers receiving 2.0k citations

Hit Papers

Cancer-associated fibrobl... 2019 2026 2021 2023 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongyan Liu China 18 851 614 437 348 307 55 2.0k
Xiuling Zhi China 27 1.1k 1.3× 509 0.8× 399 0.9× 384 1.1× 170 0.6× 63 2.3k
Rossano Lattanzio Italy 29 1.3k 1.5× 959 1.6× 436 1.0× 274 0.8× 369 1.2× 83 2.7k
Dale J. Hamilton United States 22 779 0.9× 365 0.6× 405 0.9× 577 1.7× 385 1.3× 64 2.4k
Vincent Bérézowski France 25 880 1.0× 514 0.8× 280 0.6× 136 0.4× 244 0.8× 49 2.5k
Anisha A. Gupte United States 25 897 1.1× 275 0.4× 370 0.8× 379 1.1× 619 2.0× 38 2.3k
Lu Zheng China 31 1.6k 1.9× 557 0.9× 842 1.9× 449 1.3× 219 0.7× 140 3.0k
Whaseon Lee‐Kwon United States 28 1.6k 1.9× 377 0.6× 251 0.6× 290 0.8× 292 1.0× 56 2.5k
Jie Yin China 31 1.6k 1.8× 478 0.8× 829 1.9× 293 0.8× 214 0.7× 161 3.1k
Iván P. Uray United States 20 1.3k 1.6× 434 0.7× 267 0.6× 160 0.5× 404 1.3× 40 2.3k
Fumi Takahashi‐Yanaga Japan 32 2.1k 2.4× 639 1.0× 309 0.7× 195 0.6× 149 0.5× 89 3.3k

Countries citing papers authored by Tongyan Liu

Since Specialization
Citations

This map shows the geographic impact of Tongyan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongyan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongyan Liu more than expected).

Fields of papers citing papers by Tongyan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongyan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongyan Liu. The network helps show where Tongyan Liu may publish in the future.

Co-authorship network of co-authors of Tongyan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Tongyan Liu. A scholar is included among the top collaborators of Tongyan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongyan Liu. Tongyan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiajia, Ziheng Bai, Tongyan Liu, et al.. (2025). Genetically Engineered Light‐Responsive In Situ Hydrogels for Immunomodulation and Multimodal Therapy in Metastatic Triple‐Negative Breast Cancer. Advanced Science. 13(3). e12355–e12355.
3.
Zhang, Yixuan, Weiyi Zhang, Rongjie Cheng, et al.. (2025). RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 106–106. 1 indexed citations
4.
Qian, Jinjun, et al.. (2025). DACFusion: Dual Asymmetric Cross-Attention guided feature fusion for multispectral object detection. Neurocomputing. 635. 129913–129913. 3 indexed citations
6.
Zhu, Pengcheng, Zhitong Li, Yuxiang Sun, Tongyan Liu, & Rong Yin. (2024). Persist or resist: Immune checkpoint inhibitors in EGFR‐mutated NSCLC. Cancer Science. 116(3). 581–591. 3 indexed citations
7.
Wang, Xinying, et al.. (2023). Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression. International Journal of Pharmaceutics. 643. 123284–123284. 17 indexed citations
8.
Wang, Xinying, et al.. (2023). Catechol chitosan coated dual-loaded liposomes based on oxidation and saccharification mechanisms for enhancing skin anti-aging effects. International Journal of Biological Macromolecules. 256(Pt 2). 128342–128342. 5 indexed citations
9.
Ma, Zhifei, Hao Chen, Zhijun Xia, et al.. (2023). Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing. Journal of Experimental & Clinical Cancer Research. 42(1). 169–169. 11 indexed citations
10.
Wang, Siwei, Chencheng Han, Tongyan Liu, et al.. (2021). FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma. SHILAP Revista de lepidopterología. 11(2). e316–e316. 11 indexed citations
11.
Zhang, Quanli, Run Shi, Yongkang Bai, et al.. (2021). Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma. Cancer Communications. 41(6). 492–510. 26 indexed citations
12.
Han, Chencheng, Hong Li, Zhifei Ma, et al.. (2021). MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma. Cell Death and Disease. 12(5). 424–424. 33 indexed citations
14.
Liu, Tongyan, Panqi Fang, Chencheng Han, et al.. (2019). Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer. Journal of Cellular and Molecular Medicine. 24(1). 711–721. 15 indexed citations
15.
Sun, Hai‐Jian, Mingxia Zhao, Xingsheng Ren, et al.. (2016). Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway. Antioxidants and Redox Signaling. 24(18). 1045–1057. 92 indexed citations
16.
Liu, Tongyan. (2015). Design of Information Batch Import and Smart Match Function Based on Network Remote Experimental Platform. Research and Exploration in Laboratory.
17.
Sun, Hai‐Jian, Tongyan Liu, Feng Zhang, et al.. (2015). Salusin-β contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(9). 1709–1718. 63 indexed citations
18.
Gao, Juan, Feng Zhang, Hai‐Jian Sun, et al.. (2014). Transneuronal tracing of central autonomic regions involved in cardiac sympathetic afferent reflex in rats. Journal of the Neurological Sciences. 342(1-2). 45–51. 13 indexed citations
19.
Liu, Tongyan. (2011). Shear type dynamic transformation in high manganese steels analyzed by EBSD technique. Dianzi xianwei xuebao. 1 indexed citations
20.
Lin, Kai, Tongyan Liu, & Hongwei Ge. (2009). A Clustering Hierarchy Based on Data Fusion in Wireless Sensor Networks. 8. 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026